Skip to content

Boston Scientific Corp Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: October 28, 2026 results vs estimates

Boston Scientific Corp · E.BSX.NYSE · United States
Use symbol E.BSX.NYSE in our API & Excel add-in to retrieve this data ↓
42.69
(+0.01%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -100%
Trend -100%
Bubble Risk LOW
Realised Volatility (20D) 32.85%

Boston Scientific Corp Forecast

Boston Scientific Corp short-term momentum is strongly negative (up over 0 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (0 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 32.9% a year, a typical one-standard-deviation range is 40.71–44.67 over a week, 38.64–46.74 over a month and 28.66–56.72 over a year. (Signals as of 1 Nov 2026.)

Boston Scientific Corp Price Chart

MacroFinance.ai

Boston Scientific Corp Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Boston Scientific Corp
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Boston Scientific Corp
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Boston Scientific Corp
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Boston Scientific Corp
P/E
17.76x
Cheap vs own history
QoQ −12.3%
YoY −65.8%
now 17.76116.88 low54.49 high
ⓘP/E As of 22 Nov 2026.See Boston Scientific Corp returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Boston Scientific Corp
P/S
2.94x
Cheap vs own history
QoQ −16.8%
YoY −60.7%
now 2.9422.89 low7.85 high
ⓘP/S As of 22 Nov 2026.See Boston Scientific Corp returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Boston Scientific Corp
P/B
2.42x
Cheap vs own history
QoQ −18.8%
YoY −60.9%
now 2.41852.38 low6.49 high
ⓘP/B As of 22 Nov 2026.See Boston Scientific Corp returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Boston Scientific Corp
EV/EBITDA
13.97x
Cheap vs own history
QoQ −8.8%
YoY −54.9%
now 13.972913.13 low32.39 high
ⓘEV/EBITDA As of 22 Nov 2026.See Boston Scientific Corp returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Boston Scientific Corp
EV/Sales
3.48x
Cheap vs own history
QoQ −15.4%
YoY −56.7%
now 3.48053.43 low8.41 high
ⓘEV/Sales As of 22 Nov 2026.See Boston Scientific Corp returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Boston Scientific Corp
FCF Yield
5.4%
Strong vs own history
QoQ +10.1%
YoY +103.6%
now 5.37382.52 low5.86 high
ⓘFCF Yield As of 22 Nov 2026.See Boston Scientific Corp returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
Boston Scientific Corp
Earnings Yield
5.6%
Strong vs own history
QoQ +14.1%
YoY +192.6%
now 5.63031.84 low5.92 high
ⓘEarnings Yield As of 22 Nov 2026.See Boston Scientific Corp returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Boston Scientific Corp
Market Cap
$62.0B
Mid-range vs own history
QoQ −16.6%
YoY −57.2%
now 61985.8860,955 low151,913 high
ⓘMarket Cap As of 22 Nov 2026.See Boston Scientific Corp returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Boston Scientific Corp
Net Debt
$11.3B
High vs own history
QoQ −6.1%
YoY +5.3%
now 113449,505 low12,085 high
ⓘNet Debt As of 22 Nov 2026.See Boston Scientific Corp returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Boston Scientific Corp
Net Debt / EBITDA
2.16x
Mid-range vs own history
QoQ +0.8%
YoY +0.8%
now 2.16161.73 low2.16 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Boston Scientific Corp returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Boston Scientific Corp
Current Ratio
1.36x
Mid-range vs own history
QoQ +10.1%
YoY −9.5%
now 1.36491.24 low1.9 high
ⓘCurrent Ratio As of 22 Nov 2026.See Boston Scientific Corp returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Boston Scientific Corp
Quick Ratio
0.81x
Mid-range vs own history
QoQ +10.0%
YoY −15.6%
now 0.81040.74 low1.22 high
ⓘQuick Ratio As of 22 Nov 2026.See Boston Scientific Corp returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Boston Scientific Corp
Interest Coverage
10.72x
Strong vs own history
QoQ −7.9%
YoY +17.7%
now 10.72079.11 low11.64 high
ⓘInterest Coverage As of 22 Nov 2026.See Boston Scientific Corp returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Boston Scientific Corp
Debt / Equity
0.47x
Low vs own history
QoQ −7.9%
YoY −9.4%
now 0.46640.43 low0.51 high
ⓘDebt / Equity As of 22 Nov 2026.See Boston Scientific Corp returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Boston Scientific Corp
Piotroski F-Score
7
7
QoQ −12.5%
YoY −12.5%
now 77 low8 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Boston Scientific Corp returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
Boston Scientific Corp
Altman Z-Score
2.97
Mid-range vs own history
QoQ −9.4%
YoY −46.3%
now 2.97092.91 low5.75 high
ⓘAltman Z-Score As of 22 Nov 2026.See Boston Scientific Corp returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  19 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  21 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Boston Scientific Corp, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Boston Scientific Corp fundamentals: income statement, balance sheet & cash flow

Boston Scientific Corp reported revenue of $20.07bn and net income of $2.89bn in FY2025, the year ended 31 December 2025 — revenue up 19.9% and net income up 55.7% on the prior year. Free cash flow was $3.66bn. These figures are as reported in the filings, not restated: 35 fiscal years and 143 quarters of history, back to December 1991. 173 FINRA short-interest settlements are published alongside them, back to June 2019.

Revenue (FY2025)
$20.07bn
+19.9%
Net income
$2.89bn
+55.7%
Gross margin
69.01%
Free cash flow
$3.66bn
+38.3%
Net debt
$10.37bn
Shares short (30 Oct 2026)
35.11m
1.65 days to cover
Boston Scientific Corp income statement, annual, as reported · USD billions unless stated
USD billionsFY2025FY2024FY2023FY2022FY2021
Period end31 Dec 202531 Dec 202431 Dec 202331 Dec 202231 Dec 2021
Revenue20.0716.7514.2412.6811.89
Cost of revenue6.226.485.414.973.71
Gross profit13.8510.278.837.718.18
Research & development2.051.621.411.321.20
Selling, general & admin.—5.98———
Operating income3.972.642.181.821.20
EBITDA5.103.943.452.742.51
Interest expense0.350.390.270.460.34
Pre-tax income3.392.281.991.141.08
Income tax0.490.440.390.440.04
Net income2.891.851.590.701.04

Download Boston Scientific Corp fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.BSX.NYSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 35 fiscal years and 143 quarters, the filing vintages behind each number and API access.
Create free account

Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.

Research on Boston Scientific Corp

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Boston Scientific Corp Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Boston Scientific Corp; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Boston Scientific Corp’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Boston Scientific Corp behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Boston Scientific Corp (United States)

Boston Scientific Corp is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Belo Sun Mining Corp.

Frequently asked questions

What is Boston Scientific Corp?
Boston Scientific Corp is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Boston Scientific Corp price?
The latest close is 42.69 (1 Nov 2026), +0.01% on the day. The price at the top of the page refreshes during the trading day.
Is Boston Scientific Corp in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly negative (0 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly negative (0 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Boston Scientific Corp?
20-day realised volatility is 32.9% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 9.5% over a month and 4.6% over a week.
What factors affect Boston Scientific Corp?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Boston Scientific Corp, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Boston Scientific Corp?
58 backtested tactical asset allocation strategies trade Boston Scientific Corp through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Boston Scientific Corp returns analysed?
The Statistical Distribution of Returns section shows the distribution of Boston Scientific Corp daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Boston Scientific Corp historical data?
In the Free historical data section of this page: the last 10 years of Boston Scientific Corp daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Boston Scientific Corp historical data (last 10 years)

Browse or instantly download the last 10 years of Boston Scientific Corp daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.BSX.NYSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-2041.98
2026-11-1942.99
2026-11-1843.64
2026-11-1743.03
2026-11-1643.69
2026-11-1344.34
2026-11-1244.2
2026-11-1145.13
2026-11-1044.7
2026-11-0944.02
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.